Custom Library Construction & Screening Service for Pet Antibody Discovery

Service Introduction

Purpose-Built Phage Display Libraries for Veterinary Antibody Programs

Custom phage display library construction creates a project-specific repertoire when an existing library cannot adequately represent the required species, immune history, breed, disease context, antibody format, or sequence design. The resulting genotype–phenotype linkage enables large antibody populations to be enriched against a defined antigen through iterative selection.

Creative Biolabs connects repertoire design, molecular construction, library quality control, biopanning, clone confirmation, sequencing, and optional antibody production within one workflow. Each program is configured around target biology and downstream use, helping veterinary research teams obtain traceable scFv, Fab, or other antibody candidates supported by sequence and binding data.

Customized phage display library development for pet antibody discovery

Integrated Service Scope

Library Formats Selected for Repertoire, Target, and Development Needs

The most useful custom library is not defined by clone count alone. Source material, variable-gene coverage, insert integrity, display performance, and the planned selection strategy must work together.

Projects may begin with donor lymphocytes, immune tissues, extracted RNA, supplied sequence data, purified antigen, or target-expressing cells, depending on the agreed design.

Immune Library Construction

Immune libraries capture antibody variable-region repertoires after exposure to a relevant antigen or disease context. We can evaluate species, donor strategy, sample type, immune response, RNA quality, and desired antibody format before primer design and amplification. This route can enrich the starting repertoire for antigen-experienced sequences, making it useful when a strong and relevant immune source is available for a canine, feline, or other veterinary program.

Naïve and Synthetic Library Design

Naïve libraries draw variable genes from non-immunized repertoires and can support screening across multiple target classes. Synthetic or semi-synthetic designs introduce planned diversity into selected complementarity-determining regions while retaining chosen frameworks. We align framework choice, CDR randomization, codon design, length distribution, theoretical diversity, and expression constraints with the desired fragment format and downstream engineering strategy.

Library QC and Target-Specific Screening

Constructed libraries are assessed for transformation output, insert rate, sequence diversity, frame correctness, display, and representative clone quality before screening. Biopanning can then incorporate purified antigen, captured antigen, cells, homolog depletion, tag depletion, competitive selection, or off-rate pressure. Clone-level assays and sequencing identify confirmed, nonredundant binders that can advance into soluble expression and characterization.

Project Workflow

From Repertoire Planning to Sequence-Defined Antibody Leads

Stage gates connect library quality, enrichment behavior, clone specificity, and lead-selection evidence throughout the discovery workflow.

Consultation & DesignDefine source, format, diversity goals, antigen, controls, and deliverables.

Library ConstructionGenerate variable genes, assemble fragments, clone, transform, and rescue phage.

Library Quality ControlAssess size, insert rate, diversity, sequence quality, and display performance.

Biopanning & ScreeningEnrich target binders and confirm individual clones with controlled assays.

Lead DeliverySequence unique hits and provide optional expression and characterization data.

Stage	Technical Activities	Representative Outputs	Key Decision
Project Design	Review species, donor or sequence source, antibody format, target presentation, controls, and performance criteria.	Library architecture, sample plan, antigen plan, and acceptance criteria.	Which repertoire and format best fit the program?
Library Construction	Prepare RNA and cDNA when applicable, amplify variable genes, assemble scFv or Fab inserts, clone into phagemid, transform, and rescue.	Custom phage display library with documented construction records.	Has construction produced adequate scale and integrity?
Library QC	Measure transformants, insert frequency, sequence diversity, reading-frame quality, display, and soluble-expression indicators.	QC dataset defining functional library readiness.	Does the library meet screening specifications?
Panning and Hit Screening	Perform iterative selection, depletion, enrichment monitoring, clone isolation, and primary binding confirmation.	Confirmed target-binding clones and enrichment data.	Which clones are specific and reproducible?
Sequence and Characterization	Sequence positive clones, cluster unique families, express selected fragments, and run agreed orthogonal assays.	Sequence-defined leads, optional purified material, and final report.	Which candidates should progress to engineering?

Recommended Starting Information

Target name, sequence, species relevance, and mechanism
Available antigen, cells, DNA, RNA, lymphocytes, or tissues
Immune status and collection details for donor-derived material
Preferred scFv, Fab, VHH, or other display format
Required counter-targets and cross-reactivity profile
Desired final material, assays, and sequence package

Typical Final Deliverables

Library design and construction summary
Library size, insert, diversity, and display QC
Biopanning enrichment and clone-screening results
Unique DNA and amino acid sequences
Optional purified fragments or reformatted antibodies
Final report with candidate-selection rationale

Choose a library strategy before committing valuable samples

Share the available repertoire source, antigen, target class, species context, and downstream goal. We can help define whether an immune, naïve, synthetic, or premade route is appropriate.

Peer-Reviewed Veterinary Evidence

Published Data on Antibody Phage Library Construction

Bashir and Paeshuyse summarized the construction of antibody phage libraries for veterinary applications. The figure traces donor-derived peripheral blood mononuclear cells through mRNA isolation, reverse transcription, variable-region amplification, scFv or Fab assembly, and phagemid cloning, illustrating the molecular decisions that establish genotype–phenotype linkage before library screening.

These study elements align with Creative Biolabs' custom library service scope: sample and repertoire assessment, species-aware primer strategy, variable-gene recovery, fragment assembly, vector construction, bacterial transformation, and library quality control. The resulting library can then enter target-specific biopanning, clone confirmation, sequence analysis, soluble expression, and downstream veterinary antibody characterization.

Molecular construction route from PBMC-derived immunoglobulin genes to scFv and Fab phagemid libraries. (OA Literature) — Fig.1 Synthesis and cloning of scFv and Fab fragments in phagemid vectors.^1,3

Service Advantages

Why Choose Creative Biolabs for Custom Library Discovery?

Our service connects veterinary repertoire design with measurable library QC, target-aware selection, and downstream antibody development options.

Species-Aware Repertoire Design

Library architecture reflects veterinary species, sample source, target biology, and intended format.

Documented Library Quality

Size, insert integrity, diversity, sequencing, and display metrics support screening readiness.

Target-Adapted Selection

Positive, negative, cell-based, competitive, and off-rate strategies address challenging antigens.

Connected Lead Development

Expression, characterization, reformatting, and engineering can continue from documented hit sequences.

Frequently Asked Questions

Custom Library Construction and Screening FAQs

Projects may use immune, naïve, synthetic, or semi-synthetic repertoires and formats such as scFv, Fab, or other feasible antibody fragments. The choice depends on species, available biological material, antigen history, desired diversity, target difficulty, downstream antibody format, and whether the project prioritizes antigen-experienced sequences or broader reusable coverage.

Depending on the species and project design, starting material may include peripheral blood lymphocytes, lymphoid tissues, isolated total RNA, or other agreed immune-cell sources. Sample availability, collection timing, immune response, handling, shipment, viability, RNA integrity, and ethical or institutional requirements should be reviewed before the construction plan is finalized.

Quality assessment can include total transformants, insert frequency, expected fragment size, sequence diversity, germline or CDR distribution, reading-frame quality, stop-codon frequency, display level, phage titer, and representative soluble-expression behavior. The final QC panel is aligned with library architecture and the acceptance criteria agreed at project initiation.

Potential strategies include target-expressing cells, captured extracellular domains, membrane-mimetic preparations, alternating antigen presentations, and depletion against parental or off-target cells. Feasibility depends on target abundance, accessibility, conformation, internalization, cell quality, and suitable negative controls, so the antigen-presentation plan should be reviewed before screening.

Typical outputs include construction and QC records, panning and clone-screening data, unique antibody DNA and amino acid sequences, and a final report. Optional additions may include plasmid material, soluble antibody fragments, reformatted full-length antibodies, affinity or specificity data, functional assays, and a recommended shortlist for engineering or further characterization.

Partner with Creative Biolabs

Build a traceable, screening-ready repertoire around your veterinary species, biological material, antigen, and downstream objectives. Our team can connect custom library construction with hit discovery and antibody development.

References

Bashir, Shahbaz, and Jan Paeshuyse. "Construction of Antibody Phage Libraries and Their Application in Veterinary Immunovirology." Antibodies 9.2 (2020): 21. https://doi.org/10.3390/antib9020021
Panagides, Nadya, et al. "Evaluation of Phage Display Biopanning Strategies for the Selection of Anti-Cell Surface Receptor Antibodies." International Journal of Molecular Sciences 23.15 (2022): 8470. https://doi.org/10.3390/ijms23158470
Distributed under Open Access license CC BY 4.0, without modification.